1. High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
   Birgitte Bertelsen et al, 2019, npj Genomic Medicine CrossRef
2. Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach
   Samuele Lodovichi et al, 2020, International Journal of Molecular Sciences CrossRef
3. Non-small Cell Lung Cancer
   Apichat Tantraworasin et al, 2019, International Manual of Oncology Practice CrossRef
4. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
   Lei Bian et al, 2019, Molecular Cancer CrossRef
5. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population
   Marta Podralska et al, 2018, BMC Cancer CrossRef
6. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
   Sami Belhadj et al, 2023, Clinical Cancer Research CrossRef
7. Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
   Negesse Mekonnen et al, 2022, Frontiers in Oncology CrossRef